Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CAPLACIZUMAB vs CAPTOPRIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CAPLACIZUMAB vs CAPTOPRIL: Safety Overview

Metric CAPLACIZUMAB CAPTOPRIL
Total FAERS Reports 145 1,126
Deaths Reported 34 108
Death Rate 23.4% 9.6%
Hospitalizations 53 615
Average Patient Age 53.0 yrs 56.1 yrs
% Female Patients 51.2% 60.9%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer Genzyme Corporation Bryant Ranch Prepack
Route N/A ORAL
Marketing Status N/A Discontinued